Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing.

During embryonic development, the vasculature is among the first organs to form and is in charge of maintaining metabolic homeostasis by supplying oxygen and nutrients and removing waste products. As one would expect, blood vessels are critical not only for organ growth in the embryo but also for repair of wounded tissue in the adult. An imbalance in angiogenesis (a time-honored term that globally refers to the growth of new blood vessels) contributes to the pathogenesis of numerous malignant, inflammatory, ischemic, infectious, immune, and wound-healing disorders. This review focuses on the central role of the growth of new blood vessels in ischemic and diabetic wound healing and defines the most current nomenclature that describes the neovascularization process in wounds. There are now two well-defined, distinct, yet interrelated processes for the formation of postnatal new blood vessels, angiogenesis, and vasculogenesis. Reviewed are recent new data on vasculogenesis that promise to advance the field of wound healing.

[1]  I. Weissman,et al.  Wnt proteins are lipid-modified and can act as stem cell growth factors , 2003, Nature.

[2]  T. Rabelink,et al.  Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress? , 2005, Antioxidants & redox signaling.

[3]  D. Buerk,et al.  Stimulation of perivascular nitric oxide synthesis by oxygen. , 2003, American journal of physiology. Heart and circulatory physiology.

[4]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[5]  C. Heeschen,et al.  Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells , 2003, Nature Medicine.

[6]  S. Rafii,et al.  Role of c-kit/Kit ligand signaling in regulating vasculogenesis , 2003, Thrombosis and Haemostasis.

[7]  J. Isner,et al.  Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.

[8]  L. To,et al.  The biology and clinical uses of blood stem cells. , 1997, Blood.

[9]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[10]  D. Lambert,et al.  Prevalence of lower limb ulceration in an urban health district , 1992, The British journal of surgery.

[11]  D. Buerk,et al.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. , 2007, The Journal of clinical investigation.

[12]  R. Putnam,et al.  Oxygen measurements in brain stem slices exposed to normobaric hyperoxia and hyperbaric oxygen. , 2001, Journal of applied physiology.

[13]  M. Pinget,et al.  Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. , 2003, Diabetes care.

[14]  A. Zeiher,et al.  Mobilizing endothelial progenitor cells. , 2005, Hypertension.

[15]  E. Faglia,et al.  Hyperbaric Oxygen in Diabetic Gangrene Treatment , 1987, Diabetes Care.

[16]  Z. Wood.  Hyperbaric oxygen in the management of chronic wounds. , 2002, British journal of nursing.

[17]  S. Thom.  Effects of hyperoxia on neutrophil adhesion. , 2004, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[18]  D G Smith,et al.  The Independent Contributions of Diabetic Neuropathy and Yasculopatny in Foot Ulceration: How great are the risks? , 1995, Diabetes Care.

[19]  M. Herlyn,et al.  Adenoviral mediated gene transfer of PDGF‐B enhances wound healing in type I and type II diabetic wounds , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[20]  C. Verfaillie,et al.  Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.

[21]  P. Sheffield.  Measuring tissue oxygen tension: a review. , 1998, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[22]  K. Shankar,et al.  Streptozotocin-induced diabetic mice are resistant to lethal effects of thioacetamide hepatotoxicity. , 2003, Toxicology and applied pharmacology.

[23]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[24]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[25]  A. Supe,et al.  Hyperbaric oxygen therapy in diabetic foot. , 1992, Journal of postgraduate medicine.

[26]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[27]  M. Herlyn,et al.  Fibroblast‐dependent differentiation of human microvascular endothelial cells into capillary‐like, three‐dimensional networks , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  M. Herlyn,et al.  VEGF‐A and αVβ3 integrin synergistically rescue angiogenesis via N‐Ras and PI3‐K signaling in human microvascular endothelial cells , 2003 .

[29]  Consensus development conference on diabetic foot wound care. 7-8 April 1999, Boston, MA. American Diabetes Association , 1999, Advances in wound care : the journal for prevention and healing.

[30]  E H Wagner,et al.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes. , 1999, Diabetes care.

[31]  T. K. Hunt,et al.  Respiratory gas tensions and pH in healing wounds. , 1967, American journal of surgery.

[32]  T. Springer,et al.  Expression of Stromal-Derived Factor-1 Is Decreased by IL-1 and TNF and in Dermal Wound Healing1 , 2001, The Journal of Immunology.

[33]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[34]  A. D. de Vos,et al.  KDR (VEGF Receptor 2) Is the Major Mediator for the Hypotensive Effect of VEGF , 2002, Hypertension.

[35]  P. Cianci.  Consensus Development Conference on diabetic foot wound care: a randomized controlled trial does exist supporting use of adjunctive hyperbaric oxygen therapy. , 2000, Diabetes care.

[36]  S. Rafii,et al.  Angiogenic Factors Reconstitute Hematopoiesis by Recruiting Stem Cells from Bone Marrow Microenvironment , 2003, Annals of the New York Academy of Sciences.

[37]  D. Buerk,et al.  Endothelial Progenitor Cell Release into Circulation Is Triggered by Hyperoxia‐Induced Increases in Bone Marrow Nitric Oxide , 2006, Stem cells.

[38]  P. Mauch,et al.  Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. , 1993, Blood.

[39]  Lynne H. Thom,et al.  Stem cell mobilization by hyperbaric oxygen , 2006, American journal of physiology. Heart and circulatory physiology.

[40]  E. Raz,et al.  Autonomous modes of behavior in primordial germ cell migration. , 2004, Developmental cell.

[41]  ToyoakiMurohara,et al.  Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001 .

[42]  B. Rumberger,et al.  Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF) , 1993, European journal of cancer.

[43]  Hiroshi Takahashi,et al.  Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon , 1999, Nature Medicine.

[44]  Frank J T Staal,et al.  Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. , 2004, Diabetes.

[45]  R. Wiltrout,et al.  Administration of recombinant human interleukin-7 to mice induces the exportation of myeloid progenitor cells from the bone marrow to peripheral sites. , 1994, Blood.

[46]  G. Reiber,et al.  The Epidemiology of Diabetic Foot Problems , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[47]  G. Gurtner,et al.  Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.

[48]  Definitions and guidelines for assessment of wounds and evaluation of healing , 2002 .

[49]  A. Morabito,et al.  Adjunctive Systemic Hyperbaric Oxygen Therapy in Treatment of Severe Prevalently Ischemic Diabetic Foot Ulcer: A randomized study , 1996, Diabetes Care.

[50]  D G Smith,et al.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. , 1999, Diabetes care.

[51]  L. Lavery,et al.  Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot. , 2000, Diabetes care.

[52]  Stephen M Bauer,et al.  Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels. , 2005, Journal of vascular surgery.

[53]  C. Temm,et al.  Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. , 2004, Journal of the American College of Cardiology.

[54]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[55]  D. Buerk,et al.  Stimulation of nitric oxide synthase in cerebral cortex due to elevated partial pressures of oxygen: an oxidative stress response. , 2002, Journal of neurobiology.

[56]  Douglas Hanahan,et al.  Signaling Vascular Morphogenesis and Maintenance , 1997, Science.

[57]  T. K. Hunt,et al.  Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. , 2000, Archives of surgery.

[58]  Katherine A. Gallagher,et al.  Hyperbaric Oxygen and Bone Marrow–Derived Endothelial Progenitor Cells in Diabetic Wound Healing , 2006, Vascular.

[59]  G. Gurtner,et al.  Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. , 2005, Blood.

[60]  M. Herlyn,et al.  VEGF-A and alphaVbeta3 integrin synergistically rescue angiogenesis via N-Ras and PI3-K signaling in human microvascular endothelial cells. , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  C. Attinger,et al.  A Review of Mechanical Adjuncts in Wound Healing: Hydrotherapy, Ultrasound, Negative Pressure Therapy, Hyperbaric Oxygen, and Electrostimulation , 2003, Annals of plastic surgery.

[62]  Irving L. Weissman,et al.  Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells , 2003, Nature.

[63]  A. Tolcher,et al.  Arterial thrombosis associated with granulocyte-macrophage colony-stimulating factor (GM-CSF) administration in breast cancer patients treated with dose-intensive chemotherapy: a report of two cases. , 1995, Cancer investigation.

[64]  T. K. Hunt,et al.  Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. , 1981, Surgery.

[65]  T. K. Hunt,et al.  The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. , 1972, Surgery, gynecology & obstetrics.

[66]  P. Kranke,et al.  Systematic review of hyperbaric oxygen in the management of chronic wounds , 2005, The British journal of surgery.

[67]  M. Putt,et al.  The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. , 2006, Journal of vascular surgery.

[68]  T. K. Hunt,et al.  Oxygen and wound healing. , 1990, Clinics in plastic surgery.

[69]  T. K. Hunt,et al.  Oxygen supply in healing tissue , 1972 .

[70]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[71]  W. Zamboni,et al.  Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. , 1997, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[72]  T. Uchida,et al.  Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony‐stimulating factor , 1996, British journal of haematology.

[73]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[74]  M. Bjellerup,et al.  A demographic survey of leg and foot ulcer patients in a defined population. , 1992, Acta dermato-venereologica.

[75]  E. Raz,et al.  Signaling pathways controlling primordial germ cell migration in zebrafish , 2004, Journal of Cell Science.

[76]  T. Phillips,et al.  Chronic cutaneous ulcers: etiology and epidemiology. , 1994, The Journal of investigative dermatology.

[77]  K. Brismar,et al.  Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up. , 2002, Journal of diabetes and its complications.

[78]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[79]  T. Miyamoto,et al.  Angina pectoris occurring during granulocyte colony‐stimulating factor‐combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia , 1997, British journal of haematology.

[80]  A. Avogaro,et al.  Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. , 2005, Journal of the American College of Cardiology.

[81]  Stephen M Bauer,et al.  Angiogenesis, Vasculogenesis, and Induction of Healing in Chronic Wounds , 2005, Vascular and endovascular surgery.

[82]  E. Masson,et al.  The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[83]  D. Scadden,et al.  Stem cell repopulation efficiency but not pool size is governed by p27kip1 , 2000, Nature Medicine.

[84]  Colin Mathers,et al.  The burden of mortality attributable to diabetes: realistic estimates for the year 2000. , 2005, Diabetes care.